Seven UBC Faculty of Medicine doctoral students have been named to the 2023/2024 cohort of UBC Public Scholars for advancing collaborative, interdisciplinary research for the public good.
The Public Scholars Initiative (PSI) was launched in 2015 to support UBC doctoral students whose research extended beyond the academy, and beyond traditional disciplinary approaches, to have a tangible impact for the public good through collaborative, action-oriented, and/or creative forms of scholarship in their dissertation work.
With more than 300 Public Scholars accepted into the program over the last eight years, the program has worked with more than 150 different partners in all societal sectors in more than 40 countries.
In 2022, the program was expanded to include doctoral students from the Okanagan campus. And for 2023, in partnership with UBC Health, the PSI program has created a health equity stream for doctoral students.
Faculty of Medicine Scholars:
Note: ** indicates researcher in the health equity stream.
Heather Rogers Anholt, Population and Public Health Project: A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
Hallie Dau, Population and Public Health Project: The Social and Economic Impact of Cervical Cancer on Women and Children in Uganda
Katherine Hastings, ** Population and Public Health Project: Co-designing a youth suicide care framework using a learning health systems approach
Mai-Lei (Maggie) Woo Kinshella, Women+ and Children’s Health Sciences Project: Investigating the relationship between maternal diet and pregnancy hypertension in sub-Saharan Africa
Himani Prajapati, Rehabilitation Sciences Project: Co-creation of Tailored Online Yoga Intervention to Improve Well-being in People with Spinal Cord Injury (SCI-Yoga)
Zeina Waheed, Population and Public Health Project: Pharmacogenomic testing for people with major depression: identifying and developing implementation strategies
Almira Zhantuyakova, Women+ and Children’s Health Sciences Project: Comprehensive Approach to Ovarian Cancer: From Equity-oriented Prevention to Novel Therapeutics